418 related articles for article (PubMed ID: 28866897)
1. Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT.
Prins FM; van der Velden JM; Gerlich AS; Kotte ANTJ; Eppinga WSC; Kasperts N; Verlaan JJ; Pameijer FA; Kerkmeijer LGW
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S147-S154. PubMed ID: 28866897
[TBL] [Abstract][Full Text] [Related]
2. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study.
Gerlich AS; van der Velden JM; Kotte ANTJ; Tseng CL; Fanetti G; Eppinga WSC; Kasperts N; Intven MPW; Pameijer FA; Philippens MEP; Verkooijen HM; Seravalli E
Radiother Oncol; 2018 Mar; 126(3):534-540. PubMed ID: 28919003
[TBL] [Abstract][Full Text] [Related]
3. Impact of Magnetic Resonance Imaging on Gross Tumor Volume Delineation in Non-spine Bony Metastasis Treated With Stereotactic Body Radiation Therapy.
Raman S; Chin L; Erler D; Atenafu EG; Cheung P; Chu W; Chung H; Loblaw A; Poon I; Rubenstein J; Soliman H; Sahgal A; Tseng CL
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):735-743.e1. PubMed ID: 29748100
[TBL] [Abstract][Full Text] [Related]
4. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A
J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628
[TBL] [Abstract][Full Text] [Related]
5. Interobserver variability in gross tumor volume contouring in non-spine bone metastases.
de la Pinta C; LaTorre RG; Martínez-Lorca A; Fernández E; Hernanz R; Martín M; Domínguez JA; Muñóz T; Canales E; Vallejo C; Alarza M; Hervás A; Garví M; Pino V; Sancho S
J Clin Transl Res; 2022 Dec; 8(6):465-469. PubMed ID: 36452000
[TBL] [Abstract][Full Text] [Related]
6. Volumetric and dosimetric impact of MRI in delineation of gross tumor volume of non-spinal vertebral metastases treated with stereotactic ablative radiation therapy.
Ilamurugu A; Chandrasekaran A; Ayyalusamy A; Prasanna Satpathy S; Reddy JM; Arora S; Subramanian S; Velayudham R
Cancer Radiother; 2021 Apr; 25(2):135-140. PubMed ID: 33422419
[TBL] [Abstract][Full Text] [Related]
7. Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system.
Giaj-Levra N; Figlia V; Cuccia F; Mazzola R; Nicosia L; Ricchetti F; Rigo M; Attinà G; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Alongi F
Radiat Oncol; 2021 Oct; 16(1):197. PubMed ID: 34627313
[TBL] [Abstract][Full Text] [Related]
8. Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.
Chapman ER; Nicholls L; Suh YE; Khoo V; Levine D; Ap Dafydd D; Van As N
Radiother Oncol; 2023 Mar; 180():109461. PubMed ID: 36634852
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
10. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
11. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
[TBL] [Abstract][Full Text] [Related]
13. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
14. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
15. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
[TBL] [Abstract][Full Text] [Related]
16. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
17. The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions.
Badakhshi H; Graf R; Prasad V; Budach V
Cancer Imaging; 2014 Jun; 14(1):25. PubMed ID: 25608761
[TBL] [Abstract][Full Text] [Related]
18. MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy.
den Hartogh MD; Philippens ME; van Dam IE; Kleynen CE; Tersteeg RJ; Pijnappel RM; Kotte AN; Verkooijen HM; van den Bosch MA; van Vulpen M; van Asselen B; van den Bongard HD
Radiat Oncol; 2014 Feb; 9():63. PubMed ID: 24571783
[TBL] [Abstract][Full Text] [Related]
19. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery.
Cox BW; Spratt DE; Lovelock M; Bilsky MH; Lis E; Ryu S; Sheehan J; Gerszten PC; Chang E; Gibbs I; Soltys S; Sahgal A; Deasy J; Flickinger J; Quader M; Mindea S; Yamada Y
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e597-605. PubMed ID: 22608954
[TBL] [Abstract][Full Text] [Related]
20. [Value of integrated positron-emission tomography and computed tomography in gross tumor volume delineation for radiotherapy for bone metastasis].
Zhu XX; Chen YQ; Chen LH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):700-2, 705. PubMed ID: 15201095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
